Enviva Inc.
NYSE:EVA
0.4198 (USD) • At close October 3, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,204.324 | 1,094.276 | 1,041.678 | 875.079 | 684.393 | 573.741 | 543.221 | 464.276 | 457.374 | 290.136 | 179.887 | 103.324 |
| Cost of Revenue
| 1,363.557 | 927.453 | 963.822 | 767.956 | 603.325 | 504.3 | 464.419 | 384.903 | 395.753 | 270.029 | 164.547 | 99.215 |
| Gross Profit
| -159.233 | 166.823 | 77.856 | 107.123 | 81.068 | 69.441 | 78.802 | 79.373 | 61.621 | 20.107 | 15.34 | 4.109 |
| Gross Profit Ratio
| -0.132 | 0.152 | 0.075 | 0.122 | 0.118 | 0.121 | 0.145 | 0.171 | 0.135 | 0.069 | 0.085 | 0.04 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 175.108 | 45.345 | 36.389 | 27.641 | 30.107 | 29.054 | 18.36 | 11.132 | 16.373 | 22.242 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 117.179 | 119.713 | 175.108 | 45.345 | 36.389 | 27.641 | 30.107 | 29.054 | 18.36 | 11.132 | 16.373 | 22.242 |
| Other Expenses
| 231.458 | 133.99 | 0.88 | 0.273 | 0.764 | 2.374 | -1.751 | 0.439 | 0.979 | 0.007 | 0.996 | 0.447 |
| Operating Expenses
| 348.637 | 253.703 | 175.108 | 45.345 | 36.389 | 27.641 | 30.107 | 29.054 | 18.36 | 11.132 | 16.373 | 22.242 |
| Operating Income
| -507.87 | -85.682 | -97.252 | 61.778 | 44.679 | 41.8 | 47.868 | 37.942 | 41.18 | 8.975 | -1.033 | -18.133 |
| Operating Income Ratio
| -0.422 | -0.078 | -0.093 | 0.071 | 0.065 | 0.073 | 0.088 | 0.082 | 0.09 | 0.031 | -0.006 | -0.175 |
| Total Other Income Expenses Net
| -177.982 | -80.192 | -64.994 | -45.725 | 83.299 | -34.848 | -33.495 | -24.479 | -9.863 | -5.214 | -4.441 | -1.627 |
| Income Before Tax
| -685.852 | -165.874 | -162.246 | 17.149 | -2.943 | 6.952 | 14.373 | 17.723 | 25.755 | 0.185 | -5.497 | -19.76 |
| Income Before Tax Ratio
| -0.569 | -0.152 | -0.156 | 0.02 | -0.004 | 0.012 | 0.026 | 0.038 | 0.056 | 0.001 | -0.031 | -0.191 |
| Income Tax Expense
| -0.042 | 2.494 | -16.975 | 0.069 | 40.108 | 1.623 | -3.14 | -3.654 | 2.623 | 8.652 | 6.398 | 16.093 |
| Net Income
| -685.994 | -168.368 | -145.271 | 17.08 | -43.051 | 6.952 | 17.513 | 21.377 | 23.174 | 0.264 | -5.439 | -34.169 |
| Net Income Ratio
| -0.57 | -0.154 | -0.139 | 0.02 | -0.063 | 0.012 | 0.032 | 0.046 | 0.051 | 0.001 | -0.03 | -0.331 |
| EPS
| -9.23 | -2.54 | -2.77 | 0.33 | -1.29 | 0.26 | 0.65 | 0.86 | 0.97 | 0.011 | -0.23 | -1.44 |
| EPS Diluted
| -9.23 | -2.51 | -2.77 | 0.33 | -1.29 | 0.25 | 0.61 | 0.84 | 0.96 | 0.011 | -0.23 | -1.44 |
| EBITDA
| -337.753 | 48.774 | 6.217 | 22.277 | 102.162 | 84.168 | 86.478 | 78.48 | 74.978 | 24.357 | 10.854 | -10.792 |
| EBITDA Ratio
| -0.28 | 0.025 | -0.003 | 0.159 | 0.142 | 0.148 | 0.161 | 0.169 | 0.164 | 0.096 | 0.066 | -0.096 |